Insider Ledger

SDEV insider buying and SEC filings, explained

NovaBay Pharmaceuticals, Inc. · CIK 1389545

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Insider activity in the last 12 months

Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Jan 16, 2026Other purchaseVance Spencer (10% owner) bought 50,109,253 Pre-Funded Warrants (Right to Buy) at $0.8500 ($42.6M), reported as a purchase (code P). New position of 50,109,253 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 4 other reporting owners.SEC filing
Filed May 19, 2026
Jan 16, 2026Other purchaseR01 Fund LP (CEO and Director) bought 53,679,974 Pre-Funded Warrants (Right to Buy) indirectly at $0.8500 ($45.6M), reported as a purchase (code P). New position of 53,679,974 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 3 other reporting owners.SEC filing
Filed May 19, 2026
Jan 16, 2026Other purchaseMichael John Kazley (CEO and Director) bought 53,679,974 Pre-Funded Warrants (Right to Buy) indirectly at $0.8500 ($45.6M), reported as a purchase (code P). New position of 53,679,974 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed May 19, 2026
Oct 16, 2025Other purchase Amended filingMichael John Kazley (CEO and Director) bought 11,332,020 Pre-Funded Warrants (Right to Buy) indirectly at $0.0000 ($0), reported as a purchase (code P). New position of 11,332,020 shares. Not marked as a 10b5-1 plan trade. This amends a filing from Nov 3, 2025.SEC filing
Filed Apr 30, 2026
Oct 16, 2025Other purchase Amended filingVance Spencer (10% owner) bought 11,332,020 Pre-Funded Warrants (Right to Buy) at $0.0000 ($0), reported as a purchase (code P). New position of 11,332,020 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 4 other reporting owners. This amends a filing from Nov 3, 2025.SEC filing
Filed Apr 30, 2026
Oct 16, 2025Other purchase Amended filingR01 Fund LP (CEO and Director) bought 11,332,020 Pre-Funded Warrants (Right to Buy) at $0.0000 ($0), reported as a purchase (code P). New position of 11,332,020 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 3 other reporting owners. This amends a filing from Nov 3, 2025.SEC filing
Filed Apr 30, 2026
Oct 16, 2025Other purchaseMichael John Kazley (CEO and Director) bought 2,702,703 Pre-Funded Warrants (Right to Buy) indirectly at $0.0000 ($0), reported as a purchase (code P). New position of 2,702,703 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Nov 3, 2025

16 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

No cluster buys in the last 12 months.

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

No 8-K filings in the last 12 months.

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow SDEV in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app